Business Daily Media

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration

  • Written by ACN Newswire - Press Releases
HONG KONG, May 24, 2021 - (ACN Newswire) - Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products

Read more //?#

SME Spending Signals Growing Confidence Among APAC Businesses: Instarem SME Spend Barometer

Inaugural report highlights spending behaviours among SMEs in Singapore, Australia, and Malaysia, revealing a strategic shift toward long-term gro...

Employment entitlements businesses need to know when hiring remote employees

In today's digitally connected world, companies are no longer limited by geographical boundaries when it comes to hiring. Tapping into overseas ta...

Remove the Guess Work in Location Planning

Planning where to open a new business location is a high-stakes decision. To help remove any guess work, Melbourne-headquartered GapMaps, a leader...

Employers and employees back Right to Disconnect but it’s complicated

Nearly three-quarters (74%) of Australian employers support the ‘Right to Disconnect’ legislation in Australia, according to a new survey by globa...

Financial headwinds continue to impact Australians as ASIC’s latest figures reveal more hardship ahead

WCT Advisory grows three-fold to handle increasing workload As the spiralling cost of living continues to wreak havoc on the average Australian...

Australia’s Spriggy Pocket Money App Dials Up Fastter To Launch Spriggy Mobile Plans

Fastter, an Australian first creative telecommunications studio that develops and manages virtual mobile networks for Australia’s largest brands, ha...